(Q35114361)

6 August 2017

1 reference

title

HDL in atherosclerosis: actor or bystander? (English)

1 reference

Cardiology and cardiovascular medicine

6 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1567-5688(03)00006-0

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1567-5688(03)00006-0

27 December 2023

2

Ernst J. Schaefer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714034

27 December 2023

author name string

Bela F. Asztalos

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714034

27 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12714034

27 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S1567568803000060?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1567-5688(03)00006-0

https://api.elsevier.com/content/article/PII:S1567568803000060?httpAccept=text/plain

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1567-5688(03)00006-0

Atherosclerosis. Supplements

27 December 2023

published in

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

21-29

1 reference

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Cholesterol and mortality. 30 years of follow-up from the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

The ABCs of cholesterol efflux

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Regulation of the concentration of pre beta high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Apolipoprotein A-I containing lipoproteins in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900006-0

7 January 2021

Identifiers

1 reference

6 August 2017

1 reference